C9134 – Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.
HCPCS Level II code · C codes: Outpatient PPS (Hospital Outpatient)
HCPCS codeC9134
- Long description
- Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.
- Short description
- Factor xiii a-subunit recomb
- Pricing indicator
53Statute- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Cross reference
- J7181
- Added
- July 1, 2014
- Last change
- January 1, 2015 – No change
- Termination date
- December 31, 2014
Frequently asked questions
What is HCPCS code C9134?
C9134 is a HCPCS Level II code for factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.. It was discontinued on December 31, 2014.
Does Medicare cover C9134?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby C codes
- C9097 – Inj, faricimab-svoa, 0.1 mg
- C9098 – Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- C9101 – Injection, oliceridine, 0.1 mg
- C9113 – Injection, pantoprazole sodium, per vial
- C9121 – Injection, argatroban, per 5 mg
- C9122 – Mometasone furoate sinus implant, 10 micrograms (sinuva)
- C9132 – Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
- C9133 – Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.
- C9135 – Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.
- C9136 – Injection, factor viii, fc fusion protein, (recombinant), per i.u.
- C9137 – Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.
- C9138 – Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.
- C9139 – Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.
- C9140 – Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.
- C9141 – Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.
- C9142 – Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.